Efficacy and safety of relugolix combination therapy in women with uterine fibroids and adenomyosis: subgroup analysis of LIBERTY 1 and LIBERTY 2

Authors

Institutions

Publication Details

Journal
Fertility and Sterility
Published
2025-05-02
DOI
https://doi.org/10.1016/j.fertnstert.2025.04.037
Citations
4
Primary Topic
Endometriosis Research and Treatment
Type
article
Field-Weighted Citation Impact
6.79
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of relugolix combination therapy in women with uterine fibroids and adenomyosis: subgroup analysis of LIBERTY 1 and LIBERTY 2

Roberta Venturella, Julie Perry, Silvia Vannuccini, Viatcheslav Rakov et al.
4 citations
Fertility and Sterility
Endometriosis Research and Treatment
6.79
article

Efficacy and safety of relugolix combination therapy in women with uterine fibroids and adenomyosis: subgroup analysis of LIBERTY 1 and LIBERTY 2

Roberta Venturella, Julie Perry, Silvia Vannuccini, Viatcheslav Rakov, William H. Catherino, Malcolm G. Munro, Ayman Al-Hendy, Elizabeth A. Stewart, Souhil Zaim, Rui Wu, Nadia Bouzegaou
article en
4 citations

Abstract

No abstract available for this paper.
Fertility and SterilityVol. 124(3)
Mayo Clinic (US), WinnMed (US), Magna Graecia University (IT), Sumitomo Dainippon Pharma (United States) (US)
Gender equality
Openalex Percentile: Top 3%
Endometriosis Research and Treatment
6.79
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.